Haas Anton, Pinter Oliver, Papaefthymiou Georg, Weger Martin, Berghold Andrea, Schröttner Oskar, Müllner Klaus, Pendl Gerhard, Langmann Gerald
Department of Ophthalmology, Karl-Franzens University, Graz, Austria.
Ophthalmology. 2002 May;109(5):909-13. doi: 10.1016/s0161-6420(02)01011-4.
To investigate the incidence and clinical findings of radiation retinopathy after single-fraction high-dose gamma knife radiosurgery for choroidal melanoma.
Retrospective noncomparative interventional case series.
Thirty-two patients with choroidal melanoma.
Review of charts, color fundus photographs, and fluorescein angiograms of 32 choroidal melanoma patients after radiosurgery. All patients were treated with the Leksell gamma knife in one fraction with a marginal dose between 40 and 80 Gy (median, 50 Gy) and were followed for at least 24 months (or until enucleation because of complications secondary to radiation).
Any clinical feature of radiation retinopathy and neovascular glaucoma.
During a mean follow-up of 38 months (range, 6-81 months) we found radiation retinopathy in 84% of our patients. The most common findings in these patients were intraretinal hemorrhages with an incidence of 70%, macular edema and capillary nonperfusion in 63%, and hard exudates in 52% of the patients. Less common were microaneurysms in 30% and retinal neovascularization in 22%. The time of onset of the various radiation-associated retinal findings ranged between 1 and 22 months. Forty-seven percent of all patients developed neovascular glaucoma. In our study there was no correlation between radiation dosage applied and clinical findings.
Single-fraction high-dose Leksell gamma knife radiosurgery of choroidal melanomas with a median marginal dose of 50 Gy is highly associated with early radiation retinopathy and with neovascular glaucoma.
探讨单次大剂量伽玛刀放射外科治疗脉络膜黑色素瘤后放射性视网膜病变的发生率及临床特征。
回顾性非对照干预性病例系列研究。
32例脉络膜黑色素瘤患者。
回顾32例脉络膜黑色素瘤患者放射外科治疗后的病历、彩色眼底照片及荧光素血管造影。所有患者均接受单次Leksell伽玛刀治疗,边缘剂量为40至80 Gy(中位数为50 Gy),并随访至少24个月(或直至因放疗并发症而摘除眼球)。
放射性视网膜病变和新生血管性青光眼的任何临床特征。
平均随访38个月(范围6至81个月),我们发现84%的患者出现放射性视网膜病变。这些患者最常见的表现为视网膜内出血,发生率为70%;黄斑水肿和毛细血管无灌注,发生率为63%;硬性渗出,发生率为52%。较少见的表现为微动脉瘤,发生率为30%;视网膜新生血管形成,发生率为22%。各种与放疗相关的视网膜病变的发病时间为1至22个月。47%的患者发生新生血管性青光眼。在我们的研究中,所应用的放射剂量与临床发现之间无相关性。
单次大剂量Leksell伽玛刀放射外科治疗脉络膜黑色素瘤,边缘剂量中位数为50 Gy,与早期放射性视网膜病变和新生血管性青光眼高度相关。